MICROBOT MEDICAL INC (MBOT) Stock News

USA - NASDAQ:MBOT - US59503A2042 - Common Stock

2.19 USD

-0.2 (-8.37%)

Last: 10/28/2025, 8:06:47 PM

2.1998 USD

+0.01 (+0.45%)

After Hours: 10/28/2025, 8:06:47 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MBOT Latest News, Press Relases and Analysis

All

Press Releases

9 days ago - By: Zacks Investment Research - Mentions: ISRG STXS PRCT

Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval

13 days ago - By: Microbot Medical Inc.

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

13 days ago - By: Microbot Medical Inc.

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

15 days ago - By: Microbot Medical Inc.

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

15 days ago - By: Microbot Medical Inc.

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

4 months ago - By: Microbot Medical Inc.

Microbot Medical® Added to the Russell Microcap® Index

22 days ago - By: Microbot Medical Inc.

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

22 days ago - By: Microbot Medical Inc.

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

a month ago - By: Microbot Medical Inc.

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

a month ago - By: Microbot Medical Inc.

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

a month ago - By: Microbot Medical Inc.

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

a month ago - By: Microbot Medical Inc.

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

a month ago - By: Microbot Medical Inc.

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

a month ago - By: Microbot Medical Inc.

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

a month ago - By: Microbot Medical Inc.

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

a month ago - By: Microbot Medical Inc.

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

2 months ago - By: Benzinga - Mentions: LSCC AVB FDX TMO ...

Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

2 months ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System

2 months ago - By: Microbot Medical Inc.

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

2 months ago - By: Benzinga - Mentions: BRKR CLDX KPTI BTAI ...

12 Health Care Stocks Moving In Monday's After-Market Session

2 months ago - By: Microbot Medical Inc.

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

2 months ago - By: Microbot Medical Inc.

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

2 months ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market

2 months ago - By: Microbot Medical Inc.

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

2 months ago - By: Microbot Medical Inc.

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

3 months ago - By: DIH Holding US, Inc. - Mentions: DHAI

DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

3 months ago - By: Microbot Medical Inc.

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

3 months ago - By: Microbot Medical Inc.

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

3 months ago - By: Microbot Medical Inc.

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

3 months ago - By: Microbot Medical Inc.

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

4 months ago - By: Yahoo Finance - Mentions: VZ

Microbot Medical Secures China Patent for LIBERTY System, Eyes Q3 2025 US Launch

4 months ago - By: Microbot Medical Inc.

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

4 months ago - By: Microbot Medical Inc.

Microbot Medical® Added to the Russell Microcap® Index

4 months ago - By: Microbot Medical Inc.

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

4 months ago - By: Microbot Medical Inc.

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

5 months ago - By: Zacks Investment Research - Mentions: ULTA GS ICE ORCL ...

Beat the Market the Zacks Way: Ryanair, Monster Beverage, Ulta Beauty in Focus

5 months ago - By: Microbot Medical Inc.

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System